Rabies update for travel medicine advisors

Clinical Infectious Diseases

Volumn 37, Issue 1, 2003, Pages 96-100

  Wilde, Henry ^a,b,f   Briggs, Deborah J ^c,e   Meslin, Francois Xavier ^d   Hemachudha, Thiravat ^a,b   Sitprija, Visith ^a,b  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^c KANSAS STATE UNIVERSITY   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f QUEEN SAOVABHA MEMORIAL INSTITUTE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DIPLOID CELL VACCINE; PURIFIED VERO CELL VACCINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG;

AFRICA; ASIA; DEVELOPING COUNTRY; DOG BITE; DRUG COST; ENDEMIC DISEASE; FINANCIAL MANAGEMENT; HORSE; HUMAN; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RABIES; RABIES VIRUS; REVIEW; RISK ASSESSMENT; RUSSIAN FEDERATION; SOUTH AND CENTRAL AMERICA; TOURISM; TRAVEL; VACCINATION; WORLD HEALTH ORGANIZATION;

ANIMALS; DOG DISEASES; DOGS; HUMANS; RABIES; RABIES VACCINES; RABIES VIRUS; TRAVEL;

EID: 0038234817     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375605     Document Type: Review

References (48)

1. World Health Organization. Annex table II. In: World health report. Geneva: World Health Organization, 2000:183.
2. Rupprecht CE, Hanlon CA, Hemachudha T. Rabies re-examined. Lancet Infect Dis 2002; 2:327-43.
3. World Health Organization. World survey of rabies no. 34. Document WHO/CDS/CSR/APH/99.6. Geneva: World Health Organization, 1999.
4. Krebs JW, Noll HR, Rupprecht CE, et al. Rabies surveillance in the United States during 2001. J Am Vet Med Assoc 2002; 221:1690-701.
5. Bhanganada K, Wilde H, Sakolsataydorn P, et al. Dog bite injuries at a Bangkok teaching hospital. Acta Tropica 1993; 55:249-55.
6. Weiss HB, Friedman DI, Coben JH. Incidence of dog bite injuries treated in emergency departments. JAMA 1998; 279:51-3.
7. Nixon J, Pearn J, McGarn F. Dog bite injuries to children: potential rabies threat to Australia. Med J Aust 1980; 1:175-6.
8. Tepsumethanon S, Tepsumethanon T, Wilde H. Risk of rabies after mammalian bites in Thai children. J Med Assoc Thai 2002; 85:77-80.
9. Warrell DA, Warrell MJ. Rabies. In: HP Lambert, ed. Infections of the central nervous system. Philadelphia: BC Decker, 1991:317-28.
10. Rupprecht CE, Hanlon CA, Hemachudha T. Rabies re-examined. Lancet Infect Dis 2002; 2:337-53.
11. Jackson AC, Wunner WH, eds. Rabies. Amsterdam: Academic Press, 2002.
12. World Health Organization. Strategies for the control and elimination of rabies in Asia: report of an interregional consultation. Document WHO/CSR/EPT/2002.8. Geneva: World Health Organization, 2002.
13. Ayele W, Fekadu M, Zewdie B, et al. Immunogenicity and efficacy of Fermi-type nerve tissue rabies vaccine in mince and in humans undergoing post-exposure prophylaxis for rabies in Ethiopia. Ethiop Med J 2001; 39:313-21.
14. World Health Organization. Rabies vaccines. Wkly Epidemiol Rec 2002; 77:109-19.
15. Wilde H, Tipkong P, Khawplod P. Economic issues in rabies treatment. J Travel Med 1999; 6:238-42.
16. Wilde H, Tipkong P, Khawplod P. Economic issues in postexposure rabies treatment. J Travel Med 1999; 6:238-42.
17. Pastoret PP, Brochier B. Epidemiology and control of fox rabies in Europe. Vaccine 1999; 17:1750-4.
18. Hanlon CA, Niezgoda M, Hamir AN, et al. First North American field release of a vaccinia-rabies glycoprotein recombinant virus. J Wildl Dis 1998; 34:228-39.
19. Perera MA, Harischandra PA, Wimalaratne O, et al. Feasibility of canine oral rabies vaccination in Sri Lanka: preliminary report. Ceylon Med J 2000; 45:61-4.
20. Wacharapluesadee S, Hemachudha T. Nucleic-acid sequencing based amplification in the rapid diagnosis of rabies. Lancet 2001; 358:892-3.
21. Wacharapluesadee S, Hemachudha H. Urine samples for rabies RNA detection in the diagnosis of rabies. Clin Infect Dis 2002; 34:874-5.
22. World Health Organization Expert Committee on Rabies. Eighth report. Technical series 824. Geneva: World Health Organization, 1992.
23. Wilde H, Sirikawin S, Subcharoen A, et al. Failure of post-exposure treatment of rabies in children. Clin Infect Dis 1996; 22:228-32.
24. Khawplod P, Wilde H, Chomchey P, et al. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? Vaccine 1996; 14:389-91.
25. Khawplod P, Wilde H, Tepsumethanon S, et al. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine (an effort to obtain early immune response without using immunoglobulin). Clin Infect Dis 2002; 35:1562-5.
26. Wilde H, Thipkong P, Sitprija V, Chaiyabutr N. Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis. Ann Intern Meal 1996; 125:233-6.
27. Wilde H. What are today's orphaned vaccines? Clin Infect Dis 2001; 33:648-50.
28. Thisayakorn U, Pancharoen C, Wilde H. Immunological and virological evaluation of HIV-1 infected children after rabies vaccination. Vaccine 2001; 19:1534-7.
29. World Health Organization. Recommendations on rabies postexposure treatment and the correct technique of intradermal immunization against rabies. Document EMC.ZOO 96.6. Geneva: World Health Organization, 1996.
30. Sriaroon C. Rabies in a Thai child treated with the 8-site post-exposure regimen without rabies immune globulin. Vaccine (in press).
31. Martinez L, ed. International travel and health. Geneva: World Health Organization, 2002.
32. Bernard KW, Fishbein DB. Pre-exposure rabies prophylaxis for travelers: are the benefits worth the cost? Vaccine 1991; 9:833-6.
33. LeGuerrier P, Pilon PA, Deshaies D, Allard R. Pre-exposure rabies prophylaxis for the international traveler: a decision analysis. Vaccine 1996; 14:167-76.
34. Bernard KW, Fishbein DB. Rabies virus. In: Mandel GL, ed. Principles and practice of infectious diseases. London: Churchill Livingston, 1995:1527-42.
35. Thraenhart O, Krenzfelder M, Hillebrandt I, et al. Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccine in man. Clin Immunol Immunopathol 1994; 71:287-92.
36. Briggs DJ, Schwenke JR. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine 1992; 10:125-9.
37. Strady A, Lang J, Lienard M, et al. Antibody persistence following preexposure regimens of cell-culture rabies vaccine: 10-year follow-up and proposal for a new booster policy. J Infect Dis 1998; 177:1290-5.
38. Jaijaroensup W, Limsusanno S, Khawplod P, et al. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination. J Travel Med 1999; 6:234-7.
39. Khawplod P, Benjavongkulchai M, Limusanno S, et al. Four-site intradermal boosters in previously rabies vaccinated subjects. J Travel Med 2002; 9:153-5.
40. Briggs DJ, Dreesen DW, Nicolay U, et al. Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose postexposure booster regimen for previously immunized persons. Vaccine 2000; 19:1055-60.
41. Holie E. Diagnosis of lyssavirus infection confirmed in case of human rabies in Scotland. Eurosurveillance Weekly. 28 November2002:48.
42. Morrill P, Niezgoda M, Rupprecht C. Use of serology in human rabies diagnosis [abstract 73]. In: Program and abstracts of the XII International Meeting on Research Advances and Rabies Control in the Americas (Oaxaca, Mexico). Washington, DC: Pan American Health Organization, 2002:52.
43. Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis 2003; 36:60-3.
44. Bingham J. Report on a consultation for the Office International des Epizootie (OIE) to investigate an outbreak of rabies on the island of Flores, Indonesia. Paris: OIE Document, 2000.
45. Wilde H. WHO technical advisory mission on intradermal rabies vaccination. Rabies outbreak: Flores Island, Indonesia. Report to Division of Zoonotic Diseases. Geneva: World Health Organization, 2000.
46. Hanlon CA, Niezgoda M, Morrill PA, et al. The incurable wound revisited: progress in human rabies prevention? Vaccine 2001; 19:2273-9.
47. Rabies monoclonal antibody cocktail for rabies post exposure treatment: report of a WHO consultation. Geneva: World Health Organization, 2002.
48. Briggs DJ, Schweitzer K. Importation of dogs and cats to rabies-free areas of the world. Vet Clin North Am Small Anim Prac 2001; 31:573-83.